Read More News Summit Therapeutics Partners With Akeso Inc. In Deal For Up To $5B To In-License Breakthrough Innovative Bispecific Antibody By Benzinga Newsdesk December 6, 8:35 AM Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced a definitive agreement of its partnership with Akeso Inc. (HKEX Code: 9926.HK, "Akeso"), SMMT
Read More Analyst Ratings News Price Target Truist Securities Maintains Hold on Qualys, Raises Price Target to $125 By Benzinga Newsdesk July 26, 8:13 AM Truist Securities analyst Joel Fishbein maintains Qualys (NASDAQ:QLYS) with a Hold and raises the price target from $115 to $125. QLYS
Read More Cryptocurrency Markets Uncategorized Many Crypto Platforms Default Whilst Well-Managed Businesses Capitalize By Marcus Sotiriou October 10, 11:19 AM Uncertainty defines the current situation around global markets, as concerns of war escalation heightens. BTC
Read More Insider Trades Markets News Pre-Market Outlook Short Ideas Trading Ideas Couchbase, Lyft And 2 Other Stocks Insiders Are Selling By Lisa Levin February 6, 9:07 AM The Nasdaq dropped by more than 190 points on Friday. Investors, meanwhile, focused on some notable insider trades. BASE